Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results

SEATTLE, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
February 18, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

SEATTLE, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...
February 06, 2025 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

SEATTLE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
October 31, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award

SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the...
October 30, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
October 29, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

SEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
October 08, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
September 17, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

SEATTLE, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for comprehensively...
August 14, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced the company...
July 30, 2024 08:00 ET | Source: Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...